Kaleo

Kaleo is owned by Marathon Asset Management. Marathon Asset Management has a direct presence in 2 countries.

They are in:

• Holding50%
• Pharmaceuticals50%

View the org chart displaying its 19 main executives

Most searched biographies at Kaleo

• Ron Gunn, President and Chief Executive Officer
• Randy Raisman, Director
• Evan Bedil, Director

Popular executive movements at Marathon Asset Management

• Alex Howell has joined the company as Senior Managing Director and Head of European Alternative Credit  (posted on November 17 2023).

Create your alert
to follow the executive moves at Kaleo.

Marathon Asset Management has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Kaleo

• News Archive - Kaléo
• News Archive - Kaléo
• News Archive - Kaléo
• News Archive - Kaléo
• News Archive - Kaléo
• News Archive - Kaléo
• News Archive - Kaléo
• News Archive - Kaléo
• News Archive - Kaléo
• News Archive - Kaléo
• View more press releases Close

Social media about Kaleo

• Kaleo on Wikipedia, Google News & Yahoo Finance
• Kaleo on LinkedIn, Twitter & YouTube

Contact by email its executives including Ron Gunn

Call Kaleo at +1 804...

View the org chart

Register to receive your alert

Report an error